Skip to content

    DEN Networks Limited

    DENTALKART
    Healthcare·5 Jun 2026
    Management Summary

    Vasa Denticity reported a total income of ₹283 crores for FY26, with core business growing 33% and a significant increase in new dentists. However, the company faced challenges including a decline in gross margins to 23.7% by Q4 due to own brand stockouts and a weaker rupee, leading to a fall in EBITDA margins from 10% to 4%. The planned IDS Denmed acquisition was abandoned, and management acknowledged past mistakes in supply chain and inventory management, committing to a focus on core business, improved cash flow, and restoring margins.

    Highlights

    10
    • Total income grew to ₹283 crores on continuing operations for FY26.

    • Core business grew 33% in FY26.

    • Added over 70,000 new dentists, a 62% jump, now serving 1.44 lakh customers.

    • Smileworks currently at ₹4.8 crores annual run rate, targeting ₹10-12 crores by year-end.

    • Two in three new customers return within 6 months.

    • Optimized warehouses and saved money on other expenses.

    • Own brand stockouts reduced from 33% to 14.6% and are being corrected.

    • EBITDA margins are expected to return to mid-teens in 3-4 years, with FY26 decline considered a one-off.

    • Cash flow is expected to improve in the next couple of years.

    • Sufficient funds are available for growth, with a debt line of ₹15 crores available for future needs.

    Concerns

    9
    • Deliberately exited ₹39 crores of low-margin trading in FY26.

    • Own brand stockouts pulled gross margins from 34% to 23.7% by Q4 FY26.

    • Weaker rupee raised the cost of imported products, compressing EBITDA.

    • Abandoned the IDS Denmed acquisition due to cultural differences and integration challenges.

    • Negative operating cash flow for the past 3 years.

    • EBITDA margins fell from 10% to 4% in FY26.

    • Revenue per order declined from ₹4,600 in FY25 to ₹3,670 in FY26.

    • Inventory increased by ₹27 crores for the whole year, despite stockouts in high-margin products.

    • Material cost was 77% in the March quarter.

    Key financials

    Metrics

    14

    Periods

    4

    Headline

    7
    • Total Income (Continuing Ops)
      ₹283 Cr
    • Core Business Growth
      33%
    • Gross Margin (Earlier)
      34%
    • EBITDA Margin (Earlier)
      10%
    • Material Cost (March Qtr)
      77%

    Q4 FY26

    1
    • Gross Margin
      23.7%

    FY25

    1
    • Revenue per Order
      ₹4,600

    FY26

    5
    • EBITDA Margin
      4%
    • Revenue per Order
      ₹3,670
    • Inventory Increase
      ₹27 Cr
    • Offline Segment Growth
      85%
    • Online Segment Growth
      25%

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Debt disclosed

    M&A

    IDS Denmed

    acquisition · abandoned

    Liquidity

    Undrawn ₹15 crores

    Company has necessary funds available as growth capital and for future growth, with a debt line of 15 crores available.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Top Line Doubling
    Double every 3 to four years
    Medium
    Revenue
    Smileworks Annual Run Rate
    10 to 12 crores
    High
    Margin
    EBITDA Margin
    mid-teens
    Medium
    Inventory
    Inventory Days
    below 120 days (short term), below 100 days (long term)
    Medium
    Inventory
    Own Brand Stockouts
    5 to 7%
    Medium
    Logistics
    Warehouses for 2-day delivery
    Close to 25
    Low
    Logistics
    Logistic Cost
    reduce
    Medium

    Gross Margin Improvement

    next quarter / ongoing
    Current23.7% (Q4 FY26)
    TargetImprovement towards 34% (earlier level)

    Why it matters

    Gross margin recovery is key to overall profitability, especially after stockout issues.

    Own brand stockouts pulled our gross margins from around 34% to 23.7% by Q4... Now since our own brands and all the research we have done over the years on the right set of products in our brands is coming back, we expect the gross margins to come back to a certain level and the EBITDA coming back towards higher numbers.

    How to verify

    key_financials.metrics[label='Gross Margin (Q4 FY26)']

    Risks & concerns

    7
    RiskSeverity

    Own brand stockouts and supply chain issues

    Miscalculations in ordering and long lead times led to stockouts, impacting gross margins (from 34% to 23.7% by Q4) and sales.Management acknowledged

    high

    Weaker rupee impacting imported product costs

    A weaker rupee raised the cost of imported products, contributing to compressed EBITDA.Management acknowledged

    medium

    Negative operating cash flow trend

    The company has had negative operating cash flow for the past 3 years, though management expects improvement.Analyst acknowledged

    medium

    Decline in revenue per order

    Revenue per order decreased from ₹4,600 in FY25 to ₹3,670 in FY26, attributed to exiting offline trading activities.Analyst acknowledged

    medium

    High material cost in Q4 FY26

    Material cost was 77% in the March quarter, indicating pressure on gross margins.Analyst acknowledged

    high

    Competition from traditional market and difficulty in passing on price increases

    Fear of losing customers in a traditional market prevents immediate passing on of price increases, impacting margins.Analyst acknowledged

    medium

    Challenges in scaling quick commerce profitably

    A pilot for 3-4 hour delivery in Delhi NCR resulted in losses, indicating unit economics challenges for rapid expansion.Management acknowledged

    low

    Q&A highlights

    8

    “So, this market is mostly a traditional market where the price rise reflects in the real market after some time because of the traditional supply chain and if we increase the prices we fear that we might lose some customers. So it takes us some time to increase or decrease prices.”

    Analyst questioned why price increases weren't passed on, impacting margins, given the company's market position. Management cited fear of losing customers in a traditional market.

    asked by Chintan Parikh

    2 min read6 chapters

    Detailed Narrative

    01

    FY26 Performance Overview and Strategic Exits

    Vasa Denticity reported a total income of ₹283 crores for FY26 from continuing operations. The core business demonstrated robust growth of 33%. However, the company strategically exited ₹39 crores of low-margin trading activities, which impacted the overall revenue mix. This decision was part of a broader effort to focus on higher-value operations and improve profitability, despite the immediate impact on top-line figures.

    02

    Margin Compression and Supply Chain Challenges

    The company experienced significant margin compression in FY26, with gross margins falling from approximately 34% to 23.7% by Q4. This decline was primarily attributed to own brand stockouts, which reached 33% at one point, and the adverse impact of a weaker rupee on imported product costs. Consequently, EBITDA margins decreased from 10% to 4%. Management acknowledged internal supply chain issues and miscalculations in ordering as key contributors to these challenges.

    03

    Customer Growth and Market Penetration

    Vasa Denticity successfully added over 70,000 new dentists in FY26, marking a 62% increase and expanding its customer base to 1.44 lakh. The company continues to focus on tier 2 and tier 3 cities in India, where the dental market is structurally underserved. A positive indicator of customer satisfaction and retention is that two in three new customers return within six months, demonstrating the effectiveness of their online-first platform.

    04

    Abandonment of IDS Denmed Acquisition

    The planned acquisition of IDS Denmed was abandoned after 9 months of engagement. Management cited significant cultural differences between a traditional supply chain company and Dentalkart's tech-first approach, as well as the substantial time and effort required for integration, as primary reasons. The decision was made to avoid diverting attention from Dentalkart's core business and ensure sustained focus on internal growth and operational improvements.

    05

    Digital Dentistry and Smileworks Subsidiary

    The company is actively building dental infrastructure for the next decade, with a strong focus on digital dentistry. Its subsidiary, Smileworks, which manufactures prostheses like crowns and bridges, is currently operating at an annual run rate of ₹4.8 crores and is projected to reach ₹10-12 crores by the end of the year. This segment represents a strategic investment in customized, high-value products, although the overall digital dentistry adoption in India is still in its early stages.

    06

    Future Outlook and Strategic Priorities

    Management expressed confidence in doubling the top line every 3 to 4 years and aims to restore EBITDA margins to mid-teens within the same timeframe, viewing the FY26 margin decline as a one-off📎. Key priorities for FY27 include enhancing customer service, achieving faster delivery (targeting 2-day delivery in tier 2 cities with potentially 25 warehouses), and expanding product categories. The company also plans to improve cash flow and optimize inventory levels to below 120 days in the short term and below 100 days long term.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.